Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$601M |
| 2 |
Moderna
MRNA
|
+$557M |
| 3 |
Analog Devices
ADI
|
+$448M |
| 4 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$445M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$406M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$652M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$512M |
| 3 |
TSMC
TSM
|
+$378M |
| 4 |
JPMorgan Chase
JPM
|
+$318M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$305M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.12% |
| 2 | Financials | 12.68% |
| 3 | Healthcare | 12.53% |
| 4 | Consumer Discretionary | 11.26% |
| 5 | Communication Services | 9.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Duluth Holdings
DLTH
$155M
| $1.76M | ﹤0.01% |
129,048
-7,477
| -5% | -$119K |
|
3352
Verrica Pharmaceuticals
VRCA
$89.7M
| $1.76M | ﹤0.01% |
14,045
-647
| -4% | -$72.5K |
|
|
ENLC
3353
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $1.76M | ﹤0.01% |
257,666
-40,912
| -14% | -$240K |
|
|
FORA
3354
DELISTED
Forian
FORA
| $1.75M | ﹤0.01% |
169,670
+104,736
| +161% | +$1.16M |
|
3355
Elicio Therapeutics
ELTX
$73.5M
| $1.74M | ﹤0.01% |
17,832
+11,379
| +176% | +$1.23M |
|
3356
Western Midstream Partners
WES
$19.2B
| $1.74M | ﹤0.01% |
83,035
-36,892
| -31% | -$735K |
|
3357
Heritage Insurance Holdings
HRTG
$889M
| $1.73M | ﹤0.01% |
253,917
+5,706
| +2% | +$41.1K |
|
|
NBEV
3358
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
| $1.73M | ﹤0.01% |
1,242,556
+200,582
| +19% | +$365K |
|
3359
Black Diamond Therapeutics
BDTX
$96.8M
| $1.72M | ﹤0.01% |
203,454
-6,833
| -3% | -$67.5K |
|
3360
Duolingo
DUOL
$6.28B
| $1.72M | ﹤0.01% |
+10,340
| New | +$1.57M |
|
3361
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.1B
| $1.72M | ﹤0.01% |
3,140,453
+352,427
| +13% | +$19.5M |
|
|
IMGO
3362
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $1.72M | ﹤0.01% |
+85,709
| New | +$1.84M |
|
3363
Capital Bancorp
CBNK
$608M
| $1.71M | ﹤0.01% |
70,877
-5,563
| -7% | -$124K |
|
|
AFCG
3364
AFC Gamma
AFCG
$61.4M
| $1.7M | ﹤0.01% |
115,138
+15,171
| +15% | +$220K |
|
|
STR
3365
DELISTED
Sitio Royalties
STR
| $1.69M | ﹤0.01% |
90,020
-7,521
| -8% | -$140K |
|
|
FTH
3366
Faeth Therapeutics
FTH
$702M
| $1.69M | ﹤0.01% |
8,038
+4,287
| +114% | +$780K |
|
3367
Torrid Holdings
CURV
$254M
| $1.68M | ﹤0.01% |
+109,131
| New | +$2.58M |
|
3368
Gulfport Energy Corp
GPOR
$2.9B
| $1.68M | ﹤0.01% |
+20,444
| New | +$1.42M |
|
3369
GeneDx Holdings
WGS
$1.93B
| $1.68M | ﹤0.01% |
+6,708
| New | +$2.3M |
|
|
VOXX
3370
DELISTED
VOXX International Corporation Class A
VOXX
| $1.68M | ﹤0.01% |
146,648
-7,326
| -5% | -$83.8K |
|
3371
DarioHealth
DRIO
$70.9M
| $1.66M | ﹤0.01% |
6,090
-268
| -4% | -$77.3K |
|
|
TIG
3372
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
| $1.66M | ﹤0.01% |
160,179
-721
| -0.4% | -$8.57K |
|
|
ADN
3373
DELISTED
Advent Technologies
ADN
| $1.65M | ﹤0.01% |
6,313
+3,032
| +92% | +$738K |
|
|
BRFS
3374
DELISTED
BRF SA
BRFS
| $1.64M | ﹤0.01% |
327,194
-1,195,533
| -79% | -$5.64M |
|
|
CSLT
3375
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $1.64M | ﹤0.01% |
1,045,346
-22,567
| -2% | -$44.2K |
|
Similar funds
Northern Trust's Q3 2021 Portfolio in Review
As of Q3 2021, Northern Trust held 4,828 positions worth $565B, down 0.48% from $568B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Northern Trust's Q3 2021 filing shows 242 new, 1,428 increased, 2,705 reduced and 176 closed positions. Its largest new stake was Dimensional International Value ETF: 4,656,805 shares worth $152M. The largest sale was Alphabet (Google) Class C, an estimated $652M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q3 2021 buy was Dimensional International Value ETF: 4,656,805 shares worth $152M.
- Northern Trust added most to Johnson & Johnson in Q3 2021, an estimated $601M increase.
- Northern Trust's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $652M.
- Northern Trust fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $512M.
- Northern Trust's ten largest holdings make up 22% of its $565B portfolio in Q3 2021.
- Northern Trust opened 242 new positions and closed 176 in Q3 2021.
- Northern Trust's portfolio value fell 0.48% quarter-over-quarter to $565B.
Based on Northern Trust's 13F filing for Q3 2021, filed 15 Nov 2021.